IBS vs IBD: Key Differences in Symptoms and Treatment

What is the difference between IBS and IBD?

Irritable Bowel Syndrome (IBS) is a functional gut disorder causing recurring abdominal discomfort without visible bowel inflammation. Inflammatory Bowel Disease (IBD) is a group of chronic autoimmune conditions — including Crohn's disease and ulcerative colitis — that cause measurable inflammation and tissue damage in the digestive tract. IBD is generally considered more serious than IBS.

S.L. Raheja Hospital in Mumbai provides specialist Gastro-Intestinal Science services for patients experiencing symptoms of either condition, from initial diagnosis through to long-term management.

What are the symptoms of IBS and IBD, and how do they differ?

Both conditions affect the digestive tract and share several symptoms, which is why self-diagnosis is unreliable. The key distinction lies in the presence of systemic and structural signs in IBD that are absent in IBS.

Common symptoms of IBS include:

• Recurring abdominal cramping or pain, often relieved after a bowel movement
• Bloating and excess gas
• Alternating diarrhoea and constipation (or predominantly one type)
• Mucus in the stool
• Urgency to use the toilet
• Feeling of incomplete bowel emptying
• Symptoms triggered or worsened by stress or certain foods

Common symptoms of IBD include:

• Persistent diarrhoea, often with blood or pus in the stool
• Abdominal pain and cramping
• Unintended weight loss
• Fatigue and anaemia
• Fever during flare-ups
• Reduced appetite
• In Crohn's disease: symptoms can affect any part of the GI tract, including the mouth and anus
• In ulcerative colitis: symptoms are confined to the colon and rectum

How is Crohn's disease different from ulcerative colitis?

Crohn's disease and ulcerative colitis are both forms of Inflammatory Bowel Disease, but they differ in the location and pattern of inflammation within the digestive tract.

How is IBD diagnosed, and can a colonoscopy detect IBS?

IBD is diagnosed through a combination of clinical assessment, laboratory tests, endoscopic procedures, and imaging. There is no single test for IBS — it is diagnosed based on symptom criteria (Rome IV criteria) after ruling out structural disease.

Diagnostic tools used for IBD include:

• Colonoscopy with biopsy — the primary method to visualise inflammation and obtain tissue samples
• Upper endoscopy (gastroscopy) — used when Crohn's disease affecting the upper GI tract is suspected
• Blood tests — checking for anaemia, elevated inflammatory markers (CRP, ESR), and nutritional deficiencies
• Stool tests — faecal calprotectin is a useful marker of gut inflammation
• MRI or CT enterography — imaging to assess the small bowel and detect complications

A colonoscopy can detect IBD but cannot diagnose IBS — IBS leaves no visible structural changes. If the colonoscopy is normal and symptoms persist, a gastroenterologist will apply symptom-based criteria to assess for IBS.

What is the treatment for IBS and IBD?

Treatment approaches differ significantly because IBS is a functional condition while IBD involves active immune-mediated inflammation requiring disease-modifying therapy.

IBS management typically includes:

• Dietary modifications — low-FODMAP diet is commonly recommended
• Stress management and psychological support (cognitive behavioural therapy)
• Antispasmodic medications for cramping
• Laxatives or anti-diarrhoeal agents depending on the predominant symptom
• Gut-directed therapies and probiotics (under medical guidance)

IBD treatment options include:

• Aminosalicylates (5-ASA) — first-line for mild to moderate ulcerative colitis
• Corticosteroids — used to induce remission during flare-ups
• Immunomodulators (azathioprine, methotrexate) — for maintaining remission
• Biologic therapies (anti-TNF agents, vedolizumab, ustekinumab) — for moderate to severe IBD
• Surgery — when medication fails or complications arise

Patients with IBD also benefit from nutritional support and regular monitoring for complications, including colorectal cancer surveillance. For patients managing related metabolic conditions, the Endocrinology team at S.L. Raheja Hospital can provide integrated care where needed.

What should you eat if you have IBS or IBD?

Diet plays an important role in managing symptoms for both conditions, though the specific guidance differs. There is no universal IBD or IBS diet — recommendations should be personalised by a gastroenterologist or clinical dietitian.

General dietary guidance for IBS:

• Follow a low-FODMAP diet under dietitian supervision — this reduces fermentable carbohydrates that trigger symptoms
• Eat smaller, more frequent meals
• Limit caffeine, alcohol, and carbonated drinks
• Identify and avoid personal trigger foods (common ones include onions, garlic, wheat, and dairy)
• Maintain adequate fibre intake, adjusting type based on whether constipation or diarrhoea predominates

General dietary guidance for IBD:

• During flare-ups: low-residue, easily digestible foods to reduce bowel load
• Avoid raw vegetables, high-fibre foods, and seeds during active inflammation
• Ensure adequate protein and caloric intake to counteract malabsorption
• Supplement vitamin D, B12, iron, and calcium as directed — deficiencies are common in IBD
• Stay well hydrated, especially during diarrhoea-predominant episodes

When should you see a gastroenterologist for gut symptoms?

Many people tolerate mild gut symptoms without seeking care. However, certain signs indicate that a specialist evaluation is needed without delay.

Consult a gastroenterologist if you experience any of the following:

• Diarrhoea or abdominal pain lasting more than 4 weeks
• Blood or mucus in the stool on more than one occasion
• Unintended weight loss of more than 3–4 kg over a short period
• Fever accompanying gut symptoms
• Nocturnal symptoms that wake you from sleep (uncommon in IBS)
• Anaemia or persistent fatigue without a clear cause
• A family history of IBD or colorectal cancer
• Symptoms that are worsening despite dietary changes

Early diagnosis of IBD allows treatment to begin before significant bowel damage occurs. IBS, while not dangerous, significantly affects quality of life and responds well to structured management.

How does S.L. Raheja Hospital in Mumbai support patients with IBS and IBD?

S.L. Raheja Hospital in Mahim, Mumbai offers a structured Gastro-Intestinal Science programme that covers the full diagnostic and treatment pathway for both IBS and IBD. The gastroenterology team provides endoscopic evaluation, evidence-based medical management, and coordinated care with dietetics and other specialities where required.

Patients with IBD-related complications or those requiring haematological assessment — such as anaemia workup — can access the hospital's Haematology services within the same facility. For patients whose IBD overlaps with metabolic or nutritional concerns, integrated specialist input is available on-site.